CELLGEN DIAGNOSTIC

Cellgen is developing an immuno-oncology companion diagnostic platform that enables doctors to administer a simple, in-house blood test that will measure the health of the immune system. Each disposable test will help determine which patients are most likely to respond to a given immuno-oncology therapy. Immuno-oncology represents a paradigm shift in treating cancer with a unique therapeutic approach that activates the body's immune system to help fight cancer. The results from these new cancer therapies have been unprecedented, however, identifying "non-responders" is just as important as identifying "responders" as these powerful therapies have serious adverse effects and are very costly. Cellgen's technology enables "precise" immuno-oncology by ensuring the right person is taking the right drugs... Based in Irvine, California with R&D lab facilities located in San Diego, California, Cellgen's core platform is based on a portfolio of patent-pending technologies exclusively licensed..

Also known as: Cellgen

Primary location: San Diego United States